The International Eosinophil Society announces University of Birmingham researcher as a winner of the Gerald J. Gleich Award 2022.
The largest analysis of data on antibody therapies for protecting clinically extremely vulnerable people from Covid-19 shows that they are effective.
Renewed National Institute for Health and Care Research Birmingham Biomedical Research Centre continue funds for developments around inflammatory diseases
Professor Deirdre Kelly and Dr Zania Stamataki, Institute of Immunology and Immunotherapy, provide insights into increases of unexplained paediatric hepatitis.
Eight academics within the Institute of Immunology and Immunotherapy at the University of Birmingham have been promoted in the 2022 academic promotion round.
Professor Ivan Wall has been appointed as Professor of Regenerative Medicine with the Institute of Immunology and Immunotherapy at the University of Birmingham.
Patients suffering with inflammatory bowel disease were invited to take part in a focused workshop at the University of Birmingham to assess their experiences.
The relationship between oral health and overall health has been a focus for research for some time, explain Professors Iain Chapple and Tariq Iqbal.
A UK research study looking into a new approach to treat primary sclerosing cholangitis, a rare disease where the body's immune attacks its own liver.
Certain blood cancer and arthritis patients have a significantly reduced antibody response to double COVID-19 vaccination in the first six months of being treated with a widely used drug, reveals a new study.
Patients with primary and secondary immunodeficiency are at higher risk of mortality following SARS-CoV-2 infection compared with the general population, according to a new study led by the University of Birmingham.
A COVID-19 booster vaccination markedly increases immune response in residents and staff within care homes, making it vital that people living and working in these settings get their third 'jab', a new study reveals.